Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
NVCT
#3038
Nuvectis Pharma, Inc. Common Stock
8.8
6
-0.78%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
-0.78%
Changement Mensuel
+0.68%
Evolution sur 6 mois
+32.24%
Changement Annuel
+27.85%
Clôture Précédente
8.9
3
Open
8.8
6
Bid
Ask
Low
8.8
6
High
8.8
6
Volume
17
Marchés
Actions des Marchés US
Soins de Santé
NVCT
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
19.32 M
23.39 M
23.63 M
25.46 M
25.61 M
26.49 M
—
Valuation ratios
Enterprise value
104.33 M
108.05 M
201.01 M
163.36 M
118.8 M
168.41 M
651.59 M
Price to earnings ratio
-5.42
-4.87
-8.65
-6.38
-4.39
-5.72
-25.14
Price to sales ratio
—
—
—
—
—
—
—
Price to cash flow ratio
7.59
7.56
14.55
11.48
8.49
10.29
44.81
Price to book ratio
2.09
9.53
3.26
2.45
1.74
8.94
16.39
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.24
0.34
0.18
0.23
0.21
0.23
0.85
Return on equity %
0.38
0.64
0.25
0.38
0.31
0.4
1.34
Return on invested capital %
—
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
2.74
2.09
3.28
2.66
3.07
2.38
11.4
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
—
—
—
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.14
0.14
0.21
0.16
0.2
0.18
0.75
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
1
1.08
1.5
1.25
1.56
1.45
5.76
Net current asset value per share
1
1.09
1.51
1.26
1.57
1.45
5.8
Tangible book value per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Working capital per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Book value per share
0.64
0.57
1.05
0.79
1.06
0.84
3.74
Nouvelles
Nuvectis initiates phase 1b trial combining NXP900 with osimertinib
Notation de l’action Nuvectis Pharma réitérée à l’achat par H.C. Wainwright
Nuvectis Pharma stock rating reiterated at Buy by H.C. Wainwright
H.C. Wainwright maintient sa recommandation d’achat sur Nuvectis Pharma avec un objectif de 10$
H.C. Wainwright reiterates Buy rating on Nuvectis Pharma stock at $10 target
Nuvectis Pharma adds former Intra-Cellular exec to board of directors
Nuvectis initiates phase 1b program for cancer drug NXP900
Nuvectis (NVCT) Q2 Loss Widens 43%
Nuvectis Pharma stock price target lowered to $10 at H.C. Wainwright
Nuvectis halts NXP800 development for ovarian cancer, shifts focus
Nuvectis reports positive drug interaction study for cancer drug NXP900
Friday’s Insider Activity: Top Buys and Sells in US Stocks